Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,875,717
-$1,339,015 QoQ
Shares Held
6,231
-35.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#337
of 784 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Derivatives in ALNY
reported options exposure · as of Jun 30, 2026CallValue
$240,824
CallShares
800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026PEAK6 LLC holds $19,544,893 across 28 Biotechnology names. ALNY ranks #3 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
67,942 | $4,800,102 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
29,460 | $2,335,883 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
6,231 | $1,875,717 | |
| 4 | EDIT |
Editas Medicine, Inc.
|
415,441 | $1,346,028 | |
| 5 | BNTX |
BioNTech SE
|
13,584 | $1,263,991 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
22,316 | $1,217,114 | |
| 7 | ASND |
Ascendis Pharma A/S
|
3,764 | $1,003,934 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
|
220,000 | $807,400 |
All Filings in ALNY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,875,717 | 6,231 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $240,824 | 800 | Call | Defined | 2026-08-13 | |
| 2026-03-31 | $330,870 | 1,000 | Call | Defined | 2026-05-14 | |
| 2026-03-31 | $3,176,352 | 9,600 | Put | Defined | 2026-05-14 | |
| 2026-03-31 | $3,214,732 | 9,716 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $20,160,855 | 50,700 | Call | Defined | 2026-03-12 | |
| 2025-12-31 | $795 | 2 | Shares | Defined | 2026-03-12 | |
| 2025-09-30 | $23,620,800 | 51,800 | Call | Defined | 2026-03-31 | |
| 2025-09-30 | $319,200 | 700 | Put | Defined | 2026-03-31 | |
| 2025-09-30 | $1,368 | 3 | Shares | Defined | 2026-03-31 | |
| 2025-06-30 | $10,793,579 | 33,100 | Call | Defined | 2026-03-26 | |
| 2025-06-30 | $423,917 | 1,300 | Put | Defined | 2026-03-26 | |
| 2025-03-31 | $3,591,266 | 13,300 | Put | Defined | 2025-05-14 | |
| 2025-03-31 | $27,002 | 100 | Call | Defined | 2025-05-14 | |
| 2025-03-31 | $619,695 | 2,295 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,518,287 | 10,702 | Shares | Defined | 2025-02-13 | |
| 2024-12-31 | $11,224,287 | 47,700 | Put | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||